Clinical Trial Update: Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)

View source ↗

Summary

A completed Pfizer-sponsored clinical trial evaluated sirolimus in recipients of kidney allografts from expanded criteria donors, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Pfizer | Conditions: Renal Transplantation | Status: COMPLETED | Results posted: 2014-01-22